FDA warns that Proton Pump Inhibitors can Increase your Risk for Fractures

FDA recommended that physicians exercise more caution in prescribing proton pump inhibitors (PPIs) in light of evidence suggesting that high doses or long-term administration of the medications may increase the risk for hip, wrist, and spine fractures. The FDA announced that it will add safety information about the possible increased risk for hip, wrist, and spine fractures to the prescription and over-the-counter (OTC) labels for PPIs, which include esomeprazole (Nexium), omeprazole (Prilosec, Zegerid), and lansoprazole (Prevacid). PPIs treat conditions such as gastroesophageal reflux disease, stomach and small intestine ulcers, and inflammation of the esophagus.

Gastroesphageal reflux, stomach ulcers and inflammation of the esophagus is best treated by focusing on the cause of the problem which can be due to food allergies, poor digestion, bacteria and parasites.

Deborah A. Wiancek, N.D.